Clinical Trial Update: A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study comparing VI-0521 to placebo in obese adolescents has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Obesity
• Obesity

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Pediatric Obesity, Childhood Obesity | Phase 4 | Status: COMPLETED | Results posted: 2018-02-05